发明名称 GHRELIN RECEPTOR AGONIST FOR TREATMENT OF CACHEXIA
摘要 The present invention relates to use of a compound of the present invention or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt, for the manufacture of a medicament for the treatment of cachexia. The invention also relates to a method for the treatment of cachexia, comprising administering the compound of the present invention or a pharmaceutical composition comprising the same to a human or an animal. The invention further relates to use of said compound, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt, in combination with one or more second active agents. Moreover, the invention relates to a pharmaceutical composition and a kit comprising the compound of the present invention or a pharmaceutically acceptable salt thereof, for the treatment of said disease.
申请公布号 EP2540721(A1) 申请公布日期 2013.01.02
申请号 EP20110747565 申请日期 2011.02.28
申请人 RAQUALIA PHARMA INC 发明人 SHIMADA, KAORU;SUDO, MASAKI;TAJIMI, MASAOMI;TAKAHASHI, NOBUYUKI;NONOMURA, KAZUHIKO
分类号 C07D471/04;A61K31/437;A61P1/14;A61P3/00;A61P7/06;A61P7/10;C07K5/06 主分类号 C07D471/04
代理机构 代理人
主权项
地址